Los Angeles, CA (February 19, 2019) — During a community conversation about Los Angeles County’s burgeoning biopharmaceutical sector, the Pharmaceutical Research and Manufacturers of America (PhRMA) made a down payment to support life science innovation, expand the local skilled workforce and provide economic stimulation within the county.
At the event, PhRMA President and CEO Stephen J. Ubl announced that in addition to joining the board of Bioscience Los Angeles County, known as BioLA. The association is making a three-year, $750,000 investment to expand the region’s development of breakthrough treatments and cures through innovation.
“PhRMA is here today for one reason – to help make Los Angeles a bioscience powerhouse on par with San Diego and the Bay Area and solidify California’s well-established prominence as a global life sciences leader,” said Ubl. “Los Angeles is home to world-class academic and research institutions, has a strong entrepreneurial spirit and a robust and diverse workforce that offer a solid foundation for bioscience innovation to take root and grow.”